New approaches are needed to manage the costs, access and adherence issues related to the GLP-1 drugs, say panelists at the ...

The FDA has approved the first generic GLP-1 specifically indicated for weight loss, according to a press release from Teva Pharmaceuticals. As Healio previously reported, Teva Pharmaceuticals ...

In December 2024, Teva also secured FDA approval for the other liraglutide brand Victoza, indicated for type 2 diabetes.

GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly ...

The Food and Drug Administration is cracking down on ingredients from potentially from unverified foreign sources and that ...

The recommendation applies to a range of GLP-1 drugs that also includes Novo Nordisk's Ozempic and Lilly's older diabetes ...

The FDA approved the first-ever generic form of a GLP-1 receptor agonist specifically indicated for weight loss, Teva ...

Teva Pharmaceuticals has launched the first generic GLP-1 drug for weight loss in adults and adolescents; a lower-cost ...

Weight-loss drugs such as Wegovy, Zepbound, and other GLP-1 medications are no longer covered for TRICARE For Life (TFL) ...

A patient’s genes may affect which GLP-1 obesity drugs work best, researchers say Other factors that influence the impact include how much people need to eat to full feel.

To check if a GLP-1 medication is covered, review your plan’s formulary. If your insurance doesn’t cover GLP-1 medications for weight loss, ask a healthcare professional about other approved uses.

Some GLP-1 agonists, like Zepbound, Wegovy, and Saxenda (liraglutide), are FDA approved for chronic weight management. Others, such as Ozempic and Victoza, are sometimes prescribed off-label for ...